MOLECULAR DOCKING STUDY OF QUINOLIN-4(1H)-ONE DERIVATIVES AS VEGFR-2 INHIBITORS FOR THE TREATMENT OF LUNG CANCER. (2025). Frontier in Medical and Health Research, 3(6), 1-15. https://fmhr.net/index.php/fmhr/article/view/712